(R)-1-[4-(3-Methoxy-phenyl)-3,6-dihydro-2H-pyridine-1-sulfonyl]-piperidine-2-carboxylic acid hydroxyamide

ID: ALA341300

PubChem CID: 44351496

Max Phase: Preclinical

Molecular Formula: C18H25N3O5S

Molecular Weight: 395.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(C2=CCN(S(=O)(=O)N3CCCC[C@@H]3C(=O)NO)CC2)c1

Standard InChI:  InChI=1S/C18H25N3O5S/c1-26-16-6-4-5-15(13-16)14-8-11-20(12-9-14)27(24,25)21-10-3-2-7-17(21)18(22)19-23/h4-6,8,13,17,23H,2-3,7,9-12H2,1H3,(H,19,22)/t17-/m1/s1

Standard InChI Key:  JYXIHNAIKGHBBF-QGZVFWFLSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  1  0  0  0  0  0999 V2000
    2.6500    0.3458    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.4375   -0.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0167   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4750    0.3375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1917   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1250    0.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7417    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9375    1.0583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0625    0.9333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9500    0.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9167    1.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8542   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7875   -0.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6792   -0.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3875    0.9333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7792   -1.8792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2625   -0.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2167    0.8958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4292   -1.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0458   -1.8750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6625    1.5958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3292   -0.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1542   -0.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6000    0.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2792    2.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6667   -1.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500   -1.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  1  1  0
  3  5  1  6
  6 14  1  0
  7 11  1  0
  8  1  2  0
  9  1  2  0
 10  6  1  0
 11  4  1  0
 12  4  1  0
 13  5  2  0
 14 12  1  0
 15 10  2  0
 16  5  1  0
 17  2  1  0
 18 15  1  0
  3 19  1  0
 20 16  1  0
 21 18  1  0
 22 10  1  0
 23 22  2  0
 24 23  1  0
 25 21  1  0
 26 17  1  0
 27 26  1  0
  7  6  2  0
 27 19  1  0
 18 24  2  0
M  END

Associated Targets(Human)

MONO-MAC-6 (495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.48Molecular Weight (Monoisotopic): 395.1515AlogP: 1.39#Rotatable Bonds: 5
Polar Surface Area: 99.18Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.71CX Basic pKa: CX LogP: 0.64CX LogD: 0.62
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.58Np Likeness Score: -0.96

References

1. Chen JJ, Dewdney N, Lin X, Martin RL, Walker KA, Huang J, Chu F, Eugui E, Mirkovich A, Kim Y, Sarma K, Arzeno H, Van Wart HE..  (2003)  Design and synthesis of orally active inhibitors of TNF synthesis as anti-rheumatoid arthritis drugs.,  13  (22): [PMID:14592482] [10.1016/j.bmcl.2003.08.076]

Source